Statements (40)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Company
|
gptkbp:acquisition |
gptkb:InvaGen_Pharmaceuticals
Niche Generics |
gptkbp:awards |
Best Employer Brand 2021
Pharma_Company_of_the_Year_2020 Best_Corporate_Social_Responsibility_2021 |
gptkbp:employees |
Over 25,000
|
gptkbp:focus |
Oncology
Respiratory diseases Women's health Diabetes Neurology Cardiovascular diseases Infectious diseases Pediatrics Chronic diseases Men's health |
gptkbp:founded |
1935
|
gptkbp:founder |
gptkb:Yusuf_Hamied
|
gptkbp:headquarters |
gptkb:Mumbai,_India
|
https://www.w3.org/2000/01/rdf-schema#label |
Cipla Global
|
gptkbp:industry |
Pharmaceuticals
|
gptkbp:operates_in |
Over 80 countries
|
gptkbp:partnerships |
gptkb:Bristol-Myers_Squibb
gptkb:Gilead_Sciences |
gptkbp:products |
Over-the-counter medications
Generic_drugs |
gptkbp:revenue |
$2.5 billion (2021)
|
gptkbp:services |
Healthcare_solutions
|
gptkbp:subsidiary |
gptkb:Cipla_Europe
gptkb:Cipla_USA gptkb:Cipla_Medpro gptkb:Cipla_South_Africa Cipla_Global_Limited |
gptkbp:sustainability_initiatives |
Energy efficiency
Waste management Water conservation Community health programs Green chemistry |
gptkbp:website |
www.cipla.com
|